KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Work In Process (2016 - 2019)

Jazz Pharmaceuticals has reported Work In Process over the past 10 years, most recently at $31.3 million for Q1 2019.

  • Quarterly results put Work In Process at $31.3 million for Q1 2019, changed N/A from a year ago — trailing twelve months through Mar 2019 was $31.3 million (changed N/A YoY), and the annual figure for FY2018 was $26.0 million, up 65.91%.
  • Work In Process for Q1 2019 was $31.3 million at Jazz Pharmaceuticals, up from $26.0 million in the prior quarter.
  • Over the last five years, Work In Process for JAZZ hit a ceiling of $31.3 million in Q1 2019 and a floor of $11.8 million in Q4 2015.
  • Median Work In Process over the past 5 years was $20.0 million (2017), compared with a mean of $20.8 million.
  • Biggest five-year swings in Work In Process: fell 16.04% in 2017 and later skyrocketed 65.91% in 2018.
  • Jazz Pharmaceuticals' Work In Process stood at $11.8 million in 2015, then surged by 57.9% to $18.7 million in 2016, then fell by 16.04% to $15.7 million in 2017, then surged by 65.91% to $26.0 million in 2018, then increased by 20.05% to $31.3 million in 2019.
  • The last three reported values for Work In Process were $31.3 million (Q1 2019), $26.0 million (Q4 2018), and $24.0 million (Q2 2018) per Business Quant data.